JMIR Publications

Journal of Medical Internet Research

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 02.05.14 in Vol 16, No 5 (2014): May

This paper is in the following e-collection/theme issue:

Works citing "Monitoring of Internet Forums to Evaluate Reactions to the Introduction of Reformulated OxyContin to Deter Abuse"

According to Crossref, the following articles are citing this article (DOI 10.2196/jmir.3397):

(note that this is only a small subset of citations)

  1. Jones MR, Carney MJ, Kaye RJ, Prabhakar A, Kaye AD. Drug Formulation Advances in Extended-Release Medications for Pain Control. Current Pain and Headache Reports 2016;20(6)
    CrossRef
  2. Coplan P, Chilcoat H, Butler S, Sellers E, Kadakia A, Harikrishnan V, Haddox J, Dart R. The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting. Clinical Pharmacology & Therapeutics 2016;100(3):275
    CrossRef
  3. Sarker A, O’Connor K, Ginn R, Scotch M, Smith K, Malone D, Gonzalez G. Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter. Drug Safety 2016;39(3):231
    CrossRef
  4. Gasior M, Bond M, Malamut R. Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations. Postgraduate Medicine 2016;128(1):85
    CrossRef
  5. Severtson SG, Ellis MS, Kurtz SP, Rosenblum A, Cicero TJ, Parrino MW, Gilbert MK, Buttram ME, Dasgupta N, BucherBartelson B, Green JL, Dart RC. Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone. Drug and Alcohol Dependence 2016;168:219
    CrossRef
  6. Maincent J, Zhang F. Recent advances in abuse-deterrent technologies for the delivery of opioids. International Journal of Pharmaceutics 2016;510(1):57
    CrossRef
  7. Gudin J, Levy-Cooperman N, Kopecky EA, Fleming AB. Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended-Release Oxycodone Formulations with Abuse-Deterrent Properties. Pain Medicine 2015;16(11):2142
    CrossRef
  8. R. Scott K, Nelson L, Meisel Z, Perrone J. Opportunities for Exploring and Reducing Prescription Drug Abuse Through Social Media. Journal of Addictive Diseases 2015;34(2-3):178
    CrossRef
  9. Peacock A, Degenhardt L, Hordern A, Larance B, Cama E, White N, Kihas I, Bruno R. Methods and predictors of tampering with a tamper-resistant controlled-release oxycodone formulation. International Journal of Drug Policy 2015;26(12):1265
    CrossRef
  10. Sellers EM, Shram MJ, Schoedel KA. The US FDA Draft Guidance for Developing Abuse-Deterrent Opioid Analgesics: 2014 and Beyond. Pharmaceutical Medicine 2014;28(6):317
    CrossRef